Spizhenko Clinic
Spizhenko Clinic
Ukraine, Kyiv
| Ukraine | Turquie | Espagne | |
| Radiothérapie pour le cancer colorectal | de $4,500 | de $7,000 | de $10,000 |
| Radiochirurgie stéréotaxique | de $10,000 | de $4,500 | de $12,000 |
| Craniotomie | de $12,000 | de $5,650 | de $25,000 |
| Couteau gamma | de $12,000 | de $6,300 | de $18,000 |
| Chimiothérapie pour le cancer du sein | de $1,200 | de $1,200 | de $3,500 |
Bookimed ne rajoute pas de frais pour les traitements de Gliome. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Gliome et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Gliome.
Le Dr Alexander Zavoloka a pratiqué plus de 8 000 interventions de chirurgie plastique, se spécialisant dans les cas complexes à la clinique Patlazhan.
Specialized neuro-oncology care for glioma in Ukraine is centered in Kyiv and Dnipro. Leading facilities like Spizhenko Clinic and Dobrobut Medical Network provide comprehensive treatment. These centers follow National Comprehensive Cancer Network (NCCN) protocols. They utilize craniotomy, radiosurgery, and chemotherapy for complex brain tumors.
Bookimed Expert Insight: Ukraine ranks 4th globally in our network for patient requests. This reflects high medical trust. While many focus on surgery, Spizhenko Clinic stands out for its 70,000+ patient volume. It combines surgery with radiosurgery under one roof. This integration often simplifies the transition from tumor removal to essential follow-up radiation.
Patient Consensus: Patients emphasize choosing Kyiv-based national centers over local general hospitals for brain tumors. They recommend confirming that the facility can coordinate pathology, MRI imaging, and adjuvant chemotherapy in one location.
Leading neuro-oncologists in Ukraine include Dr. Oksana Zemskova at the Romodanov Neurosurgery Institute and specialists at Spizhenko Clinic. These experts focus on glioblastoma using multidisciplinary protocols. Centers like Dobrobut Medical Network provide integrated care through surgery, radiation, and chemotherapy for complex brain tumors.
Bookimed Expert Insight: Private networks in Kyiv like Dobrobut and Spizhenko Clinic offer faster access to diagnostics. While Romodanov remains the academic authority, private clinics often streamline the path between consultation and surgery. This speed is vital for glioblastoma where immediate intervention preserves neurological function.
Patient Consensus: Patients emphasize finding teams that combine pathology review with radiation and chemotherapy. Reliable access to specific medications like temozolomide is often a deciding factor for families.
Ukrainian clinics provide modern glioma treatments including neurosurgical resection, radiation therapy, and chemotherapy. Specialized centers like Spizhenko Clinic and Dobrobut Medical Network utilize international NCCN protocols. Options include advanced Gamma Knife radiosurgery and maximal safe resection for tumors in delicate brain regions.
Bookimed Expert Insight: Kyiv centers demonstrate high surgical capacity with Dobrobut Medical Network performing over 11,000 operations annually. Patients should note that Spizhenko Clinic offers a full cycle of care from diagnosis to clinical trials. This integrated approach often simplifies the transition from surgery to postoperative radiotherapy within one facility.
Patient Consensus: Patients emphasize the need to confirm if a clinic coordinates care through a multidisciplinary tumor board. They also recommend verifying if the facility can perform molecular testing for IDH and MGMT markers internally.